{"transactions":[{"id":4624161,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:04:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":5484,"price":199.3032,"value":1092978.7488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 65,613 restricted stock units."}],"balance_after":286307,"source":{"system":"sec-edgar","filing":"0001462808-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000146280826000010/ownership.xml","form_type":"4"}},{"id":4624160,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-18T22:04:03.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":85,"price":195.0074,"value":16575.629,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $195.00 to $195.03, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":291791,"source":{"system":"sec-edgar","filing":"0001462808-26-000010","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000146280826000010/ownership.xml","form_type":"4"}},{"id":4618554,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":40031,"price":40.74,"value":1630862.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":88069,"derivative":{"exercise_price":40.74,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":128100},"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618553,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":52500,"price":42.45,"value":2228625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":42.45,"expiration_date":"2031-03-04","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618552,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":3270,"price":205.8075,"value":672990.525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The transaction was executed in multiple trades at prices ranging from $205.57 to $206.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F10","text":"Includes 76,251 restricted stock units."}],"balance_after":291876,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618551,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":4995,"price":204.8427,"value":1023189.2865,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The transaction was executed in multiple trades at prices ranging from $204.46 to $205.45, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":295146,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618550,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":17949,"price":203.8726,"value":3659309.2974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades at prices ranging from $203.45 to $204.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":300141,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618549,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":18869,"price":203.0606,"value":3831550.4614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades at prices ranging from $202.41 to $203.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":318090,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618548,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":21447,"price":201.7507,"value":4326947.2629,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades at prices ranging from $201.39 to $202.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":336959,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618547,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":13368,"price":200.7769,"value":2683985.5992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades at prices ranging from $200.36 to $201.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":358406,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618546,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":11833,"price":200.1145,"value":2367954.8785,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades at prices ranging from $199.36 to $200.35, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":371774,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618545,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":800,"price":198.5502,"value":158840.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades at prices ranging from $198.35 to $198.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":383607,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618544,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":40031,"price":40.74,"value":1630862.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."}],"balance_after":384407,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":4618543,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-15T22:00:04.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":52500,"price":42.45,"value":2228625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026."}],"balance_after":344376,"source":{"system":"sec-edgar","filing":"0001462808-26-000007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628171/000146280826000007/ownership.xml","form_type":"4"}},{"id":731969,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-18T20:10:00.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":4175,"price":156.1192,"value":651797.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $156.1105 to $156.8250. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 76,251 RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 653 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2026."}],"balance_after":291876,"source":{"system":"sec-edgar","filing":"0001610717-26-000243","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071726000243/form4.xml","form_type":"4"}},{"id":833377,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-19T22:57:08.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":4302,"price":99.4804,"value":427964.6808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,250 RSUs."}],"balance_after":295398,"source":{"system":"sec-edgar","filing":"0001610717-26-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071726000131/form4.xml","form_type":"4"}},{"id":866654,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T02:09:54.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":47600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":47600,"derivative":{"exercise_price":102.02,"expiration_date":"2036-02-28","underlying":"Common Stock","underlying_shares":47600},"source":{"system":"sec-edgar","filing":"0001610717-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071726000083/form4.xml","form_type":"4"}},{"id":866653,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T02:09:54.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":21100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 94,676 restricted stock units."}],"balance_after":299700,"source":{"system":"sec-edgar","filing":"0001610717-26-000083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071726000083/form4.xml","form_type":"4"}},{"id":963093,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-18T21:16:31.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":5447,"price":76.8172,"value":418423.2884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 73,576 restricted stock units."}],"balance_after":278600,"source":{"system":"sec-edgar","filing":"0001610717-25-000422","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000422/form4.xml","form_type":"4"}},{"id":1018406,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-15T21:09:49.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":5055,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-25-000361","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000361/form4.xml","form_type":"4"}},{"id":1018405,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-15T21:09:49.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":48.5416,"value":1213540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $48.03 to $48.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,000 restricted stock units."}],"balance_after":284047,"source":{"system":"sec-edgar","filing":"0001610717-25-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000361/form4.xml","form_type":"4"}},{"id":1018404,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-15T21:09:49.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4.73,"value":118250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,000 restricted stock units."}],"balance_after":309047,"source":{"system":"sec-edgar","filing":"0001610717-25-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000361/form4.xml","form_type":"4"}},{"id":1036275,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-18T20:38:06.000Z","date":"2025-09-16","kind":"sale","planned":true,"acquired":false,"shares":5367,"price":45.8249,"value":245942.2383,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 84,000 restricted stock units."}],"balance_after":284047,"source":{"system":"sec-edgar","filing":"0001610717-25-000350","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000350/form4.xml","form_type":"4"}},{"id":1040299,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":30055,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040298,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":55055,"derivative":{"exercise_price":4.73,"exercise_date":"2023-08-09","expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040297,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":1318,"price":46.9302,"value":61854.0036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $46.5450 to $47.21, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":289414,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040296,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":23682,"price":45.9175,"value":1087418.235,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $45.4650 to $46.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":290732,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040295,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":4.73,"value":118250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":314414,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040294,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":55941,"price":44.4847,"value":2488518.6027,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $44.12 to $44.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":289414,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040293,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":44059,"price":43.5771,"value":1919963.4489,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $43.12 to $44.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":345355,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1040292,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-16T00:51:43.000Z","date":"2025-09-11","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":4.73,"value":473000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 94,426 restricted stock units."}],"balance_after":389414,"source":{"system":"sec-edgar","filing":"0001610717-25-000339","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000339/form4.xml","form_type":"4"}},{"id":1106179,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-18T20:05:22.000Z","date":"2025-06-16","kind":"sale","planned":true,"acquired":false,"shares":4289,"price":39.83,"value":170830.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 94,426 RSUs."}],"balance_after":289414,"source":{"system":"sec-edgar","filing":"0001610717-25-000238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000238/form4.xml","form_type":"4"}},{"id":1196991,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-19T21:40:55.000Z","date":"2025-03-17","kind":"sale","planned":true,"acquired":false,"shares":3294,"price":39.0403,"value":128598.7482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 104,850 RSUs."}],"balance_after":293051,"source":{"system":"sec-edgar","filing":"0001610717-25-000077","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000077/form4.xml","form_type":"4"}},{"id":1228043,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T00:02:26.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":128100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2025 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":128100,"derivative":{"exercise_price":40.74,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":128100},"source":{"system":"sec-edgar","filing":"0001610717-25-000054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000054/form4.xml","form_type":"4"}},{"id":1228042,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-03-05T00:02:26.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":36600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 113,926 restricted stock units."}],"balance_after":296345,"source":{"system":"sec-edgar","filing":"0001610717-25-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071725000054/form4.xml","form_type":"4"}},{"id":1326552,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-12-18T21:07:48.000Z","date":"2024-12-16","kind":"sale","planned":true,"acquired":false,"shares":4663,"price":45.4038,"value":211717.9194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 77,326 RSUs."}],"balance_after":259745,"source":{"system":"sec-edgar","filing":"0001610717-24-000545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000545/form4.xml","form_type":"4"}},{"id":1363609,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-15T21:08:53.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":6666,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001610717-24-000522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000522/form4.xml","form_type":"4"}},{"id":1363608,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-15T21:08:53.000Z","date":"2024-11-13","kind":"sale","planned":true,"acquired":false,"shares":2888,"price":59.4509,"value":171694.1992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $59.13 to $59.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":264408,"source":{"system":"sec-edgar","filing":"0001610717-24-000522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000522/form4.xml","form_type":"4"}},{"id":1363607,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-15T21:08:53.000Z","date":"2024-11-13","kind":"sale","planned":true,"acquired":false,"shares":13778,"price":58.4856,"value":805814.5968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $58.13 to $59.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":267296,"source":{"system":"sec-edgar","filing":"0001610717-24-000522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000522/form4.xml","form_type":"4"}},{"id":1363606,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-15T21:08:53.000Z","date":"2024-11-13","kind":"exercise","planned":true,"acquired":true,"shares":16666,"price":4.09,"value":68163.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":281074,"source":{"system":"sec-edgar","filing":"0001610717-24-000522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000522/form4.xml","form_type":"4"}},{"id":1385827,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-16T20:07:44.000Z","date":"2024-10-14","kind":"exercise","planned":true,"acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":23332,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001610717-24-000510","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000510/form4.xml","form_type":"4"}},{"id":1385826,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-16T20:07:44.000Z","date":"2024-10-14","kind":"sale","planned":true,"acquired":false,"shares":2610,"price":50.0775,"value":130702.275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $49.95 to $50.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":264408,"source":{"system":"sec-edgar","filing":"0001610717-24-000510","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000510/form4.xml","form_type":"4"}},{"id":1385825,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-16T20:07:44.000Z","date":"2024-10-14","kind":"sale","planned":true,"acquired":false,"shares":14056,"price":49.3812,"value":694102.1472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $48.95 to $49.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":267018,"source":{"system":"sec-edgar","filing":"0001610717-24-000510","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000510/form4.xml","form_type":"4"}},{"id":1385824,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-10-16T20:07:44.000Z","date":"2024-10-14","kind":"exercise","planned":true,"acquired":true,"shares":16666,"price":4.09,"value":68163.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":281074,"source":{"system":"sec-edgar","filing":"0001610717-24-000510","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000510/form4.xml","form_type":"4"}},{"id":1403507,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-18T20:17:17.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":4665,"price":44.1853,"value":206124.4245,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 86,400 restricted stock units."}],"balance_after":264408,"source":{"system":"sec-edgar","filing":"0001610717-24-000486","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000486/form4.xml","form_type":"4"}},{"id":1406596,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-16T20:05:22.000Z","date":"2024-09-13","kind":"exercise","planned":true,"acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":39998,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001610717-24-000477","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000477/form4.xml","form_type":"4"}},{"id":1406595,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-16T20:05:22.000Z","date":"2024-09-13","kind":"sale","planned":true,"acquired":false,"shares":10701,"price":43.645,"value":467045.145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $43.22 to $43.91, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000477/form4.xml","form_type":"4"}},{"id":1406594,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-16T20:05:22.000Z","date":"2024-09-13","kind":"sale","planned":true,"acquired":false,"shares":5966,"price":42.7493,"value":255042.3238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $42.19 to $43.18, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":279774,"source":{"system":"sec-edgar","filing":"0001610717-24-000477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000477/form4.xml","form_type":"4"}},{"id":1406593,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-09-16T20:05:22.000Z","date":"2024-09-13","kind":"exercise","planned":true,"acquired":true,"shares":16667,"price":4.09,"value":68168.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":285740,"source":{"system":"sec-edgar","filing":"0001610717-24-000477","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000477/form4.xml","form_type":"4"}},{"id":1432472,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-15T20:48:18.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":56665,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001610717-24-000427","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000427/form4.xml","form_type":"4"}},{"id":1432471,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-15T20:48:18.000Z","date":"2024-08-13","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":42.9825,"value":716389.3275,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $42.76 to $43.42, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000427/form4.xml","form_type":"4"}},{"id":1432470,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-15T20:48:18.000Z","date":"2024-08-13","kind":"exercise","planned":true,"acquired":true,"shares":16667,"price":4.09,"value":68168.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":285740,"source":{"system":"sec-edgar","filing":"0001610717-24-000427","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000427/form4.xml","form_type":"4"}},{"id":1452520,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":73332,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452519,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":3879,"price":48.0589,"value":186420.4731,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The transaction was executed in multiple trades in prices ranging from $47.62 to $48.47, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452518,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":3800,"price":47.0219,"value":178683.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The transaction was executed in multiple trades in prices ranging from $46.62 to $47.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":272952,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452517,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":5760,"price":46.0775,"value":265406.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The transaction was executed in multiple trades in prices ranging from $45.60 to $46.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":276752,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452516,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":2128,"price":44.9353,"value":95622.3184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $44.40 to $45.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":282512,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452515,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":43.9855,"value":48384.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $43.37 to $44.29, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":284640,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1452514,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-17T20:07:16.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":true,"shares":16667,"price":4.09,"value":68168.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":285740,"source":{"system":"sec-edgar","filing":"0001610717-24-000398","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000398/form4.xml","form_type":"4"}},{"id":1468705,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-25","kind":"exercise","planned":true,"acquired":false,"shares":16467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":89999,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":16467},"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1468704,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":106466,"derivative":{"exercise_price":4.09,"exercise_date":"2023-03-13","expiration_date":"2029-03-12","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1468703,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-25","kind":"sale","planned":true,"acquired":false,"shares":16467,"price":39.057,"value":643151.619,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $39.00 to $39.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1468702,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-25","kind":"exercise","planned":true,"acquired":true,"shares":16467,"price":4.09,"value":67350.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":285540,"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1468701,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":200,"price":39,"value":7800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1468700,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-26T20:26:21.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":true,"shares":200,"price":4.09,"value":818.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 95,476 restricted stock units."}],"balance_after":269273,"source":{"system":"sec-edgar","filing":"0001610717-24-000364","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000364/form4.xml","form_type":"4"}},{"id":1473067,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-06-20T20:11:48.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":3349,"price":37.387,"value":125209.063,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $37.3867 to $37.3887, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 95,476 RSUs."}],"balance_after":269073,"source":{"system":"sec-edgar","filing":"0001610717-24-000349","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000349/form4.xml","form_type":"4"}},{"id":1565897,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-20T20:45:25.000Z","date":"2024-03-18","kind":"sale","planned":true,"acquired":false,"shares":2123,"price":31.5832,"value":67051.1336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 104,550 RSUs."}],"balance_after":270909,"source":{"system":"sec-edgar","filing":"0001610717-24-000173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000173/form4.xml","form_type":"4"}},{"id":1595717,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T21:54:03.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":179900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":179900,"derivative":{"exercise_price":29.8,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":179900},"source":{"system":"sec-edgar","filing":"0001610717-24-000131","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000131/form4.xml","form_type":"4"}},{"id":1595716,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-05T21:54:03.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":51400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 110,413 restricted stock units."}],"balance_after":273032,"source":{"system":"sec-edgar","filing":"0001610717-24-000131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000131/form4.xml","form_type":"4"}},{"id":1681534,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-10T21:26:52.000Z","date":"2024-01-08","kind":"sale","planned":true,"acquired":false,"shares":3337,"price":29.0108,"value":96809.0396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.00 to $29.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,013 restricted stock units."}],"balance_after":221632,"source":{"system":"sec-edgar","filing":"0001610717-24-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000025/form4.xml","form_type":"4"}},{"id":1687692,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-04T21:06:21.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":13330,"price":29.0986,"value":387884.338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.00 to $29.37, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,013 restricted stock units."}],"balance_after":224969,"source":{"system":"sec-edgar","filing":"0001610717-24-000008","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071724000008/form4.xml","form_type":"4"}},{"id":1697894,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-29T21:14:16.000Z","date":"2023-12-27","kind":"sale","planned":true,"acquired":false,"shares":33334,"price":29.0093,"value":966996.0062,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.00 to $29.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 59,013 restricted stock units."}],"balance_after":238299,"source":{"system":"sec-edgar","filing":"0001610717-23-000425","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000425/form4.xml","form_type":"4"}},{"id":1703300,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-12-20T22:07:32.000Z","date":"2023-12-18","kind":"sale","planned":true,"acquired":false,"shares":2088,"price":25.9016,"value":54082.5408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units (\"RSUs\") after July 15, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the RSUs award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $25.8901 to $25.909, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 59,013 RSUs."}],"balance_after":271633,"source":{"system":"sec-edgar","filing":"0001610717-23-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000413/form4.xml","form_type":"4"}},{"id":1760556,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-13T20:20:31.000Z","date":"2023-10-11","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":29.0472,"value":484129.6824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.00 to $29.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 64,875 restricted stock units."}],"balance_after":273721,"source":{"system":"sec-edgar","filing":"0001610717-23-000309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000309/form4.xml","form_type":"4"}},{"id":1776129,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-09-20T20:13:14.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":2060,"price":31.3106,"value":64499.836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $31.1033 to $31.3108, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 64,875 RSUs."}],"balance_after":290388,"source":{"system":"sec-edgar","filing":"0001610717-23-000295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000295/form4.xml","form_type":"4"}},{"id":1816215,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-03T20:17:19.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":32.4,"value":539978.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,738 restricted stock units."}],"balance_after":292448,"source":{"system":"sec-edgar","filing":"0001610717-23-000221","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000221/form4.xml","form_type":"4"}},{"id":1816214,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-03T20:17:19.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":29.1913,"value":486502.2058,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 14, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.00 to $29.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,738 restricted stock units."}],"balance_after":309114,"source":{"system":"sec-edgar","filing":"0001610717-23-000221","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000221/form4.xml","form_type":"4"}},{"id":1846439,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-06-22T20:26:53.000Z","date":"2023-06-20","kind":"sale","planned":false,"acquired":false,"shares":2102,"price":24.891,"value":52320.882,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,513 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 70,738 RSUs."}],"balance_after":325780,"source":{"system":"sec-edgar","filing":"0001610717-23-000195","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000161071723000195/form4.xml","form_type":"4"}},{"id":1942928,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-22T00:33:14.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":1230,"price":21.78,"value":26789.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $21.4115 to $21.784581, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 76,600 RSUs."}],"balance_after":326369,"source":{"system":"sec-edgar","filing":"0000899243-23-009375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000089924323009375/doc4.xml","form_type":"4"}},{"id":1973046,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-03T21:16:36.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2023 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":140000,"derivative":{"exercise_price":26.5,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001567619-23-004353","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761923004353/doc1.xml","form_type":"4"}},{"id":1973045,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-03T21:16:36.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 79,963 restricted stock units."}],"balance_after":327599,"source":{"system":"sec-edgar","filing":"0001567619-23-004353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761923004353/doc1.xml","form_type":"4"}},{"id":2078718,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-12-21T21:06:23.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":1220,"price":22.9391,"value":27985.702,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $22.47 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 39,963 RSUs."}],"balance_after":287599,"source":{"system":"sec-edgar","filing":"0001567619-22-021927","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922021927/doc1.xml","form_type":"4"}},{"id":2153451,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-09-21T20:18:10.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":1267,"price":19.0426,"value":24126.9742,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.9729 to $19.0337, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 43,325 RSUs."}],"balance_after":288819,"source":{"system":"sec-edgar","filing":"0001567619-22-017691","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922017691/doc1.xml","form_type":"4"}},{"id":2224054,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-06-22T21:03:06.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":1145,"price":17.7495,"value":20323.1775,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units (\"RSUs\") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 46,688 RSUs."}],"balance_after":290086,"source":{"system":"sec-edgar","filing":"0001567619-22-013252","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922013252/doc1.xml","form_type":"4"}},{"id":2323149,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-22T00:03:23.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":321,"price":18.6162,"value":5975.8002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $18.32 to $18.62, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 50,050 RSUs."}],"balance_after":290294,"source":{"system":"sec-edgar","filing":"0001567619-22-007326","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922007326/doc1.xml","form_type":"4"}},{"id":2354042,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-03T21:27:47.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":135800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2022 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":135800,"derivative":{"exercise_price":18.56,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":135800},"source":{"system":"sec-edgar","filing":"0001567619-22-006236","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922006236/doc1.xml","form_type":"4"}},{"id":2354041,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-03-03T21:27:47.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":38800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 50,988 Restricted Stock Units."}],"balance_after":290615,"source":{"system":"sec-edgar","filing":"0001567619-22-006236","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761922006236/doc1.xml","form_type":"4"}},{"id":2462376,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-21T21:32:24.000Z","date":"2021-12-17","kind":"sale","acquired":false,"shares":343,"price":24.41,"value":8372.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 12,188 RSUs."}],"balance_after":251815,"source":{"system":"sec-edgar","filing":"0001567619-21-022402","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761921022402/doc1.xml","form_type":"4"}},{"id":2563039,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-09-21T23:48:11.000Z","date":"2021-09-17","kind":"sale","acquired":false,"shares":335,"price":30.02,"value":10056.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 13,125 RSUs."}],"balance_after":252158,"source":{"system":"sec-edgar","filing":"0001567619-21-017416","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761921017416/doc1.xml","form_type":"4"}},{"id":2658721,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-06-22T21:18:51.000Z","date":"2021-06-17","kind":"sale","acquired":false,"shares":324,"price":34.1235,"value":11056.014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units (\"RSUs\") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $33.60 to $34.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 14,063 RSUs."}],"balance_after":252493,"source":{"system":"sec-edgar","filing":"0001567619-21-012490","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761921012490/doc1.xml","form_type":"4"}},{"id":2803067,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-09T00:42:57.000Z","date":"2021-03-04","kind":"grant","acquired":false,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 4, 2021 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":52500,"derivative":{"exercise_price":42.45,"expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001567619-21-005848","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761921005848/doc1.xml","form_type":"4"}},{"id":2803066,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-09T00:42:57.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 15,000 Restricted Stock Units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2020."}],"balance_after":252073,"source":{"system":"sec-edgar","filing":"0001567619-21-005848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761921005848/doc1.xml","form_type":"4"}},{"id":3019830,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":17248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":155055,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":17248},"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019829,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-29","kind":"exercise","acquired":false,"shares":13268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":172303,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":13268},"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019828,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-28","kind":"exercise","acquired":false,"shares":9384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from August 9, 2019 (the \"Vesting Commencement Date\"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":185571,"derivative":{"exercise_price":4.73,"expiration_date":"2029-08-08","underlying":"Common Stock","underlying_shares":9384},"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019827,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-30","kind":"sale","acquired":false,"shares":17248,"price":34.3263,"value":592060.0224,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $34.02 to $34.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":236329,"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019826,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":17248,"price":4.73,"value":81583.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":253577,"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019825,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-29","kind":"sale","acquired":false,"shares":13268,"price":34.1358,"value":452913.7944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $34.00 to $34.4550, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":236329,"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019824,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-29","kind":"exercise","acquired":true,"shares":13268,"price":4.73,"value":62757.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":249597,"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}},{"id":3019823,"issuer":{"id":606,"kind":"organization","name":"Revolution Medicines, Inc.","symbol":"RVMD"},"owners":[{"id":36791,"kind":"person","name":"Kelsey Stephen Michael","position":1,"cik":"0001462808","reported_name":"Kelsey Stephen Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-10-01T00:31:31.000Z","date":"2020-09-28","kind":"sale","acquired":false,"shares":9384,"price":34.0826,"value":319831.1184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $34.00 to $34.40, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":236329,"source":{"system":"sec-edgar","filing":"0001567619-20-017291","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1462808/000156761920017291/doc1.xml","form_type":"4"}}],"next_cursor":"2020-10-01T00:31:31.000000Z,3019823"}